SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway
Open Access
- 8 September 2017
- journal article
- laboratory investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 135 (2) , 263-272
Abstract
Spalt-like transcription factor 4 (SALL4), a oncogene, is known to participate in multiple carcinomas, and is up-regulated in glioma. However, its actual role and underlying mechanisms in the development of glioma remain unclear. The present study explored the molecular functions of SALL4 in promoting cell proliferation in glioma. The expression level of SALL4 in 69 human glioma samples and six non-tumor brain tissues was determined using real-time polymerase chain reaction (PCR). Then, we transfected U87 and U251 cell lines with siRNA, and assessed cellular proliferation and cell cycle to understand the function of SALL4, and the relationship between SALL4, PTEN and PI3K/AKT pathway. PCR confirmed that the expression of SALL4 was higher in the glioma samples than non-tumor brain tissues. Cellular growth and proliferation were dramatically reduced following inhibition of SALL4 expression. Western blot showed increase in PTEN expression when SALL4 was silenced, which in turn depressed the activation of PI3K/AKT pathway, suggesting that PTEN was a downstream target of SALL4 in glioma development. Therefore, SALL4 could act as a proto-oncogene by regulating the PTEN/PI3K/AKT signaling pathway, thereby facilitating proliferation of glioma cells.Keywords
Funding Information
- National Science Foundation of China (81372689)
- National Natural Science Foundation of China (81572475)
- Suzhou science and technology development plan item (SYS201324)
- Anti-Cancer Association Foundation of China (CSNO-2013-MSD-009)
This publication has 46 references indexed in Scilit:
- Expression of PTEN and Its Correlation with Proliferation Marker Ki-67 in Head and Neck CancerThe International Journal of Biological Markers, 2016
- Gab1 regulates SDF-1-induced progression via inhibition of apoptosis pathway induced by PI3K/AKT/Bcl-2/BAX pathway in human chondrosarcomaTumor Biology, 2015
- SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinomaOncotarget, 2015
- Stemness factor Sall4 is required for DNA damage response in embryonic stem cellsJournal of Cell Biology, 2015
- miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma CellsCellular and Molecular Neurobiology, 2015
- SALL4 positive fetal gut‐like adenocarcinoma of the duodenumPathology International, 2014
- [Role of SALL4 in regulating multi-drug resistance of small cell lung cancer and its clinical significance].2014
- Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt PathwayPLOS ONE, 2010
- Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repressionBiochemical and Biophysical Research Communications, 2007
- Functional roles of Akt signaling in mouse skin tumorigenesisOncogene, 2002